US Edition
Published • loading... • Updated
Capital Research Global Investors Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Capital Research Global Investors Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN
Capital Research Global Investors boosted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 105,749 shares of the biopharmaceutical company’s stock after acquiring an additional 3,635 shares during the period. […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
